Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.60 |
| ▸ | MEN1 | O00255 | 8/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.60 |
| ▸ | USP2 | O75604 | 7/20 | 0.60 |
| ▸ | MAPT | P10636 | 6/20 | 0.60 |
| ▸ | GAA | P10253 | 5/20 | 0.60 |
| ▸ | LMNA | P02545 | 5/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | RECQL | P46063 | 3/20 | 0.60 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.60 |
| ▸ | CASP1 | P29466 | 5/20 | 0.56 |
| ▸ | CASP7 | P55210 | 5/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.56 |
| ▸ | HBB | P68871 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29413851 | 1.00 | SLC16A3 (0.80) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL12511762 | 0.90 | SLC16A3 (0.83) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL45609 | 0.89 | SLC16A3 (1.00) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL29364862 | 0.89 | SLC16A3 (1.00) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL21620382 | 0.88 | SLC16A3 (0.80) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL10082362 | 0.88 | SLC16A3 (0.80) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL12761821 | 0.87 | SLC16A3 (0.74) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL13403675 | 0.87 | SLC16A3 (0.74) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL14129630 | 0.87 | SLC16A3 (0.74) | SLC16A3ALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL13384868 | 0.87 | SLC16A3 (0.74) | SLC16A3ALDH1A1MEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431452-B1 | Method for the optical distinction of dental materials and material used in this method | IVOCLAR AG (LI) | 1994-10-05 | — | — | EP | claimed |
| US-5102461-A | PROCESS FOR THE OPTICAL DISTINCTION OF A DENTAL MATERIAL AND DENTAL MATERIAL FOR SAID PROCESS | IVOCLAR AG (DE) | 1992-04-07 | — | — | US | claimed |
| US-12180378-B2 | Colorimetric sensor formulation and use thereof | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) | 2024-12-31 | — | — | US | disclosed |
| US-12036078-B2 | Oral products and methods for producing the same | PolySpectra, Inc. (US) | 2024-07-16 | — | — | US | disclosed |
| US-12036078-B2 | Oral products and methods for producing the same | PolySpectra, Inc. (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2023233040-A1 | ACCURATE METHOD FOR GENERATING A PHASE DIAGRAM OF A POLYMER | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-12-07 | — | — | WO | disclosed |
| US-11725077-B2 | Olefin metathesis photopolymers | PolySpectra, Inc. (US) | 2023-08-15 | — | — | US | disclosed |
| US-11725077-B2 | Olefin metathesis photopolymers | PolySpectra, Inc. (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230176067-A1 | METHODS OF CHARACTERIZING CONDENSATE-ASSOCIATED CHARACTERISTICS OF COMPOUNDS AND USES THEREOF | DEWPOINT THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| US-20230176067-A1 | METHODS OF CHARACTERIZING CONDENSATE-ASSOCIATED CHARACTERISTICS OF COMPOUNDS AND USES THEREOF | DEWPOINT THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| US-20220411692-A1 | COMPOSITION CONTAINING SEMICONDUCTOR NANOPARTICLES, COLOR FILTER, AND IMAGE DISPLAY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-12-29 | — | — | US | disclosed |
| US-20070184383-A1 | Photosensitive composition, photosensitive planographic printing plate material, and recording method of planographic printing plate material | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070110672-A1 | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors | CERCACOR LABORATORIES, INC. | 2007-05-17 | — | — | US | disclosed |
| US-20070110672-A1 | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors | CERCACOR LABORATORIES, INC. | 2007-05-17 | — | — | US | disclosed |
| US-20070059636-A1 | Light sensitive planographic printing plate material | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-03-15 | — | — | US | disclosed |
| US-20070059636-A1 | Light sensitive planographic printing plate material | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-03-15 | — | — | US | disclosed |
| US-20070009831-A1 | PLANOGRAPHIC PRINTING PLATE MATERIAL AND IMAGE FORMATION METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-11 | — | — | US | disclosed |
| US-20070009831-A1 | PLANOGRAPHIC PRINTING PLATE MATERIAL AND IMAGE FORMATION METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-11 | — | — | US | disclosed |
| US-20070003866-A1 | Photosensitive composition, photosensitive planographic printing plate material, and image forming method of the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20070003866-A1 | Photosensitive composition, photosensitive planographic printing plate material, and image forming method of the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070110672-A1 | SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors | GCKR, SYMPK, SUCNR1 | SLC16A3 950/4885ALDH1A1 4364/4885MEN1 606/4885 |
| US-12036078-B2 | Oral products and methods for producing the same | CROCC, RPAP1, RUVBL1 | SLC16A3 4556/4885ALDH1A1 4171/4885MEN1 2874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.